| In vivo protein transduction: delivery of a biologically active protein into the mouse SR Schwarze, A Ho, A Vocero-Akbani, SF Dowdy Science 285 (5433), 1569-1572, 1999 | 3362 | 1999 |
| Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis JS Wadia, RV Stan, SF Dowdy Nature medicine 10 (3), 310-315, 2004 | 2160 | 2004 |
| CDK inhibitors: cell cycle regulators and beyond A Besson, SF Dowdy, JM Roberts Developmental cell 14 (2), 159-169, 2008 | 1401 | 2008 |
| Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration H Nagahara, AM Vocero-Akbani, EL Snyder, A Ho, DG Latham, NA Lissy, ... Nature medicine 4 (12), 1449-1452, 1998 | 1290 | 1998 |
| Physical interaction of the retinoblastoma protein with human D cyclins SF Dowdy, PW Hinds, K Louie, SI Reed, A Arnold, RA Weinberg Cell 73 (3), 499-511, 1993 | 1060 | 1993 |
| Overcoming cellular barriers for RNA therapeutics SF Dowdy Nature biotechnology 35 (3), 222-229, 2017 | 1011 | 2017 |
| Cationic TAT peptide transduction domain enters cells by macropinocytosis IM Kaplan, JS Wadia, SF Dowdy Journal of Controlled Release 102 (1), 247-253, 2005 | 869 | 2005 |
| Protein transduction: unrestricted delivery into all cells? SR Schwarze, KA Hruska, SF Dowdy Trends in cell biology 10 (7), 290-295, 2000 | 847 | 2000 |
| In vivo protein transduction: intracellular delivery of biologically active proteins, compounds and DNA SR Schwarze, SF Dowdy Trends in Pharmacological Sciences 21 (2), 45-48, 2000 | 703 | 2000 |
| Protein transduction technology JS Wadia, SF Dowdy Current opinion in biotechnology 13 (1), 52-56, 2002 | 659 | 2002 |
| Function of a human cyclin gene as an oncogene. PW Hinds, SF Dowdy, EN Eaton, A Arnold, RA Weinberg Proceedings of the National Academy of Sciences 91 (2), 709-713, 1994 | 634 | 1994 |
| Synthetic protein transduction domains: enhanced transduction potential in vitro and in vivo A Ho, SR Schwarze, SJ Mermelstein, G Waksman, SF Dowdy Cancer research 61 (2), 474-477, 2001 | 587 | 2001 |
| Transmembrane delivery of protein and peptide drugs by TAT-mediated transduction in the treatment of cancer JS Wadia, SF Dowdy Advanced drug delivery reviews 57 (4), 579-596, 2005 | 541 | 2005 |
| GalNAc-siRNA conjugates: leading the way for delivery of RNAi therapeutics AD Springer, SF Dowdy Nucleic acid therapeutics 28 (3), 109-118, 2018 | 517 | 2018 |
| TAT-mediated protein transduction into mammalian cells M Becker-Hapak, SS McAllister, SF Dowdy Methods 24 (3), 247-256, 2001 | 507 | 2001 |
| Cyclin D1 stimulation of estrogen receptor transcriptional activity independent of cdk4 E Neuman, MH Ladha, N Lin, TM Upton, SJ Miller, J DiRenzo, RG Pestell, ... Molecular and cellular biology 17 (9), 5338-5347, 1997 | 499 | 1997 |
| Cyclin D activates the Rb tumor suppressor by mono-phosphorylation AM Narasimha, M Kaulich, GS Shapiro, YJ Choi, P Sicinski, SF Dowdy Elife 3, e02872, 2014 | 488 | 2014 |
| TAT transduction: the molecular mechanism and therapeutic prospects JM Gump, SF Dowdy Trends in molecular medicine 13 (10), 443-448, 2007 | 451 | 2007 |
| Cell penetrating peptides in drug delivery EL Snyder, SF Dowdy Pharmaceutical research 21, 389-393, 2004 | 442 | 2004 |
| Efficient siRNA delivery into primary cells by a peptide transduction domain–dsRNA binding domain fusion protein A Eguchi, BR Meade, YC Chang, CT Fredrickson, K Willert, N Puri, ... Nature biotechnology 27 (6), 567-571, 2009 | 416 | 2009 |
